Overview of Bleeding Disorders in Adolescent Females with Menorrhagia

Abstract Women bleed with menses, during childbirth, and after childbirth. Women are more likely to manifest a bleeding disorder as they have more opportunities to experience bleeding challenges in their lifetime. Bleeding disorders such as hemophilia and von Willebrand disease affect 2.5–3 million...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pediatric & adolescent gynecology 2010-12, Vol.23 (6), p.S15-S21
Hauptverfasser: Ahuja, Sanjay P., MD, MS, Hertweck, S. Paige, MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S21
container_issue 6
container_start_page S15
container_title Journal of pediatric & adolescent gynecology
container_volume 23
creator Ahuja, Sanjay P., MD, MS
Hertweck, S. Paige, MD
description Abstract Women bleed with menses, during childbirth, and after childbirth. Women are more likely to manifest a bleeding disorder as they have more opportunities to experience bleeding challenges in their lifetime. Bleeding disorders such as hemophilia and von Willebrand disease affect 2.5–3 million American women. The most common inherited bleeding disorder in the population is von Willebrand disease with an estimated prevalence of 1–2%. von Willebrand factor (vWF) is required to adhere platelets to exposed subendothelium and protects factor VIII from proteolysis in the circulation.1 The prevalence of vWF rises in studies involving women with menorrhagia, with estimates ranging as high as 10–20% in white women, and 1–2% among African American women.2 Other bleeding disorders seen in adolescents with menorrhagia are disorders of inherited platelet dysfunction, clotting factor deficiencies, thrombocytopenia, and disorders of the fibrinolytic pathway. Not only are women more likely to present early in their life with a bleeding disorder, they are also more likely to have other gynecologic manifestations as a result of these disorders. This article presents an overview of the problem and touches upon the different management strategies available.
doi_str_mv 10.1016/j.jpag.2010.08.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_810239000</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1083318810002500</els_id><sourcerecordid>810239000</sourcerecordid><originalsourceid>FETCH-LOGICAL-c410t-7777816cae0e02c7fb66b83126f5339051ace33a960d5a3c85310dc049b311c03</originalsourceid><addsrcrecordid>eNp9kTFPwzAQhS0EolD4AwwoG1PK2W4SR0JIUCgggRiA2XKcS3FI42InVPx7HBUYGPDik_Xek993hBxRmFCg6Wk9qVdqMWEQHkBMANItskdFxuMp52w7zCB4zKkQI7LvfQ0AWZKKXTJikPOpyPkeuX78QPdhcB3ZKrpsEEvTLqIr460r0fnItNFFaRv0GtsumuNShTlam-41esDWOveqFkYdkJ1KNR4Pv-8xeZlfP89u4_vHm7vZxX2spxS6OAtH0FQrBASms6pI00JwytIq4TyHhCqNnKs8hTJRXIuEUyg1TPOCU6qBj8nJJnfl7HuPvpNLE37WNKpF23spKLCQA4OSbZTaWe8dVnLlzFK5T0lBDvRkLQd6cqAnQchAL5iOv-P7Yonlr-UHVxCcbQQYSgZqTnptsNWBmkPdydKa__PP_9h1Y1qjVfOGn-hr27s24JNUeiZBPg37G9ZHQyOWhFZfg-aTxQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>810239000</pqid></control><display><type>article</type><title>Overview of Bleeding Disorders in Adolescent Females with Menorrhagia</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Ahuja, Sanjay P., MD, MS ; Hertweck, S. Paige, MD</creator><creatorcontrib>Ahuja, Sanjay P., MD, MS ; Hertweck, S. Paige, MD</creatorcontrib><description>Abstract Women bleed with menses, during childbirth, and after childbirth. Women are more likely to manifest a bleeding disorder as they have more opportunities to experience bleeding challenges in their lifetime. Bleeding disorders such as hemophilia and von Willebrand disease affect 2.5–3 million American women. The most common inherited bleeding disorder in the population is von Willebrand disease with an estimated prevalence of 1–2%. von Willebrand factor (vWF) is required to adhere platelets to exposed subendothelium and protects factor VIII from proteolysis in the circulation.1 The prevalence of vWF rises in studies involving women with menorrhagia, with estimates ranging as high as 10–20% in white women, and 1–2% among African American women.2 Other bleeding disorders seen in adolescents with menorrhagia are disorders of inherited platelet dysfunction, clotting factor deficiencies, thrombocytopenia, and disorders of the fibrinolytic pathway. Not only are women more likely to present early in their life with a bleeding disorder, they are also more likely to have other gynecologic manifestations as a result of these disorders. This article presents an overview of the problem and touches upon the different management strategies available.</description><identifier>ISSN: 1083-3188</identifier><identifier>EISSN: 1873-4332</identifier><identifier>DOI: 10.1016/j.jpag.2010.08.006</identifier><identifier>PMID: 20934893</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adolescent ; Antifibrinolytic Agents - therapeutic use ; bleeding disorders ; Blood Coagulation Disorders, Inherited - complications ; Blood Coagulation Disorders, Inherited - epidemiology ; Contraceptives, Oral - therapeutic use ; DDAVP ; Endometriosis - complications ; Female ; Hemorrhagic Disorders - complications ; Hemorrhagic Disorders - epidemiology ; Hemostatics - therapeutic use ; Humans ; Intrauterine Devices, Medicated ; Levonorgestrel - therapeutic use ; Menorrhagia ; Menorrhagia - diagnosis ; Menorrhagia - drug therapy ; Menorrhagia - etiology ; Menorrhagia - surgery ; Obstetrics and Gynecology ; oral contraceptives ; Ovarian Cysts - complications ; Pediatrics</subject><ispartof>Journal of pediatric &amp; adolescent gynecology, 2010-12, Vol.23 (6), p.S15-S21</ispartof><rights>North American Society for Pediatric and Adolescent Gynecology</rights><rights>2010 North American Society for Pediatric and Adolescent Gynecology</rights><rights>Copyright © 2010 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c410t-7777816cae0e02c7fb66b83126f5339051ace33a960d5a3c85310dc049b311c03</citedby><cites>FETCH-LOGICAL-c410t-7777816cae0e02c7fb66b83126f5339051ace33a960d5a3c85310dc049b311c03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jpag.2010.08.006$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20934893$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahuja, Sanjay P., MD, MS</creatorcontrib><creatorcontrib>Hertweck, S. Paige, MD</creatorcontrib><title>Overview of Bleeding Disorders in Adolescent Females with Menorrhagia</title><title>Journal of pediatric &amp; adolescent gynecology</title><addtitle>J Pediatr Adolesc Gynecol</addtitle><description>Abstract Women bleed with menses, during childbirth, and after childbirth. Women are more likely to manifest a bleeding disorder as they have more opportunities to experience bleeding challenges in their lifetime. Bleeding disorders such as hemophilia and von Willebrand disease affect 2.5–3 million American women. The most common inherited bleeding disorder in the population is von Willebrand disease with an estimated prevalence of 1–2%. von Willebrand factor (vWF) is required to adhere platelets to exposed subendothelium and protects factor VIII from proteolysis in the circulation.1 The prevalence of vWF rises in studies involving women with menorrhagia, with estimates ranging as high as 10–20% in white women, and 1–2% among African American women.2 Other bleeding disorders seen in adolescents with menorrhagia are disorders of inherited platelet dysfunction, clotting factor deficiencies, thrombocytopenia, and disorders of the fibrinolytic pathway. Not only are women more likely to present early in their life with a bleeding disorder, they are also more likely to have other gynecologic manifestations as a result of these disorders. This article presents an overview of the problem and touches upon the different management strategies available.</description><subject>Adolescent</subject><subject>Antifibrinolytic Agents - therapeutic use</subject><subject>bleeding disorders</subject><subject>Blood Coagulation Disorders, Inherited - complications</subject><subject>Blood Coagulation Disorders, Inherited - epidemiology</subject><subject>Contraceptives, Oral - therapeutic use</subject><subject>DDAVP</subject><subject>Endometriosis - complications</subject><subject>Female</subject><subject>Hemorrhagic Disorders - complications</subject><subject>Hemorrhagic Disorders - epidemiology</subject><subject>Hemostatics - therapeutic use</subject><subject>Humans</subject><subject>Intrauterine Devices, Medicated</subject><subject>Levonorgestrel - therapeutic use</subject><subject>Menorrhagia</subject><subject>Menorrhagia - diagnosis</subject><subject>Menorrhagia - drug therapy</subject><subject>Menorrhagia - etiology</subject><subject>Menorrhagia - surgery</subject><subject>Obstetrics and Gynecology</subject><subject>oral contraceptives</subject><subject>Ovarian Cysts - complications</subject><subject>Pediatrics</subject><issn>1083-3188</issn><issn>1873-4332</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kTFPwzAQhS0EolD4AwwoG1PK2W4SR0JIUCgggRiA2XKcS3FI42InVPx7HBUYGPDik_Xek993hBxRmFCg6Wk9qVdqMWEQHkBMANItskdFxuMp52w7zCB4zKkQI7LvfQ0AWZKKXTJikPOpyPkeuX78QPdhcB3ZKrpsEEvTLqIr460r0fnItNFFaRv0GtsumuNShTlam-41esDWOveqFkYdkJ1KNR4Pv-8xeZlfP89u4_vHm7vZxX2spxS6OAtH0FQrBASms6pI00JwytIq4TyHhCqNnKs8hTJRXIuEUyg1TPOCU6qBj8nJJnfl7HuPvpNLE37WNKpF23spKLCQA4OSbZTaWe8dVnLlzFK5T0lBDvRkLQd6cqAnQchAL5iOv-P7Yonlr-UHVxCcbQQYSgZqTnptsNWBmkPdydKa__PP_9h1Y1qjVfOGn-hr27s24JNUeiZBPg37G9ZHQyOWhFZfg-aTxQ</recordid><startdate>20101201</startdate><enddate>20101201</enddate><creator>Ahuja, Sanjay P., MD, MS</creator><creator>Hertweck, S. Paige, MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20101201</creationdate><title>Overview of Bleeding Disorders in Adolescent Females with Menorrhagia</title><author>Ahuja, Sanjay P., MD, MS ; Hertweck, S. Paige, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c410t-7777816cae0e02c7fb66b83126f5339051ace33a960d5a3c85310dc049b311c03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adolescent</topic><topic>Antifibrinolytic Agents - therapeutic use</topic><topic>bleeding disorders</topic><topic>Blood Coagulation Disorders, Inherited - complications</topic><topic>Blood Coagulation Disorders, Inherited - epidemiology</topic><topic>Contraceptives, Oral - therapeutic use</topic><topic>DDAVP</topic><topic>Endometriosis - complications</topic><topic>Female</topic><topic>Hemorrhagic Disorders - complications</topic><topic>Hemorrhagic Disorders - epidemiology</topic><topic>Hemostatics - therapeutic use</topic><topic>Humans</topic><topic>Intrauterine Devices, Medicated</topic><topic>Levonorgestrel - therapeutic use</topic><topic>Menorrhagia</topic><topic>Menorrhagia - diagnosis</topic><topic>Menorrhagia - drug therapy</topic><topic>Menorrhagia - etiology</topic><topic>Menorrhagia - surgery</topic><topic>Obstetrics and Gynecology</topic><topic>oral contraceptives</topic><topic>Ovarian Cysts - complications</topic><topic>Pediatrics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahuja, Sanjay P., MD, MS</creatorcontrib><creatorcontrib>Hertweck, S. Paige, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pediatric &amp; adolescent gynecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahuja, Sanjay P., MD, MS</au><au>Hertweck, S. Paige, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Overview of Bleeding Disorders in Adolescent Females with Menorrhagia</atitle><jtitle>Journal of pediatric &amp; adolescent gynecology</jtitle><addtitle>J Pediatr Adolesc Gynecol</addtitle><date>2010-12-01</date><risdate>2010</risdate><volume>23</volume><issue>6</issue><spage>S15</spage><epage>S21</epage><pages>S15-S21</pages><issn>1083-3188</issn><eissn>1873-4332</eissn><abstract>Abstract Women bleed with menses, during childbirth, and after childbirth. Women are more likely to manifest a bleeding disorder as they have more opportunities to experience bleeding challenges in their lifetime. Bleeding disorders such as hemophilia and von Willebrand disease affect 2.5–3 million American women. The most common inherited bleeding disorder in the population is von Willebrand disease with an estimated prevalence of 1–2%. von Willebrand factor (vWF) is required to adhere platelets to exposed subendothelium and protects factor VIII from proteolysis in the circulation.1 The prevalence of vWF rises in studies involving women with menorrhagia, with estimates ranging as high as 10–20% in white women, and 1–2% among African American women.2 Other bleeding disorders seen in adolescents with menorrhagia are disorders of inherited platelet dysfunction, clotting factor deficiencies, thrombocytopenia, and disorders of the fibrinolytic pathway. Not only are women more likely to present early in their life with a bleeding disorder, they are also more likely to have other gynecologic manifestations as a result of these disorders. This article presents an overview of the problem and touches upon the different management strategies available.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>20934893</pmid><doi>10.1016/j.jpag.2010.08.006</doi></addata></record>
fulltext fulltext
identifier ISSN: 1083-3188
ispartof Journal of pediatric & adolescent gynecology, 2010-12, Vol.23 (6), p.S15-S21
issn 1083-3188
1873-4332
language eng
recordid cdi_proquest_miscellaneous_810239000
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adolescent
Antifibrinolytic Agents - therapeutic use
bleeding disorders
Blood Coagulation Disorders, Inherited - complications
Blood Coagulation Disorders, Inherited - epidemiology
Contraceptives, Oral - therapeutic use
DDAVP
Endometriosis - complications
Female
Hemorrhagic Disorders - complications
Hemorrhagic Disorders - epidemiology
Hemostatics - therapeutic use
Humans
Intrauterine Devices, Medicated
Levonorgestrel - therapeutic use
Menorrhagia
Menorrhagia - diagnosis
Menorrhagia - drug therapy
Menorrhagia - etiology
Menorrhagia - surgery
Obstetrics and Gynecology
oral contraceptives
Ovarian Cysts - complications
Pediatrics
title Overview of Bleeding Disorders in Adolescent Females with Menorrhagia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T12%3A01%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Overview%20of%20Bleeding%20Disorders%20in%20Adolescent%20Females%20with%20Menorrhagia&rft.jtitle=Journal%20of%20pediatric%20&%20adolescent%20gynecology&rft.au=Ahuja,%20Sanjay%20P.,%20MD,%20MS&rft.date=2010-12-01&rft.volume=23&rft.issue=6&rft.spage=S15&rft.epage=S21&rft.pages=S15-S21&rft.issn=1083-3188&rft.eissn=1873-4332&rft_id=info:doi/10.1016/j.jpag.2010.08.006&rft_dat=%3Cproquest_cross%3E810239000%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=810239000&rft_id=info:pmid/20934893&rft_els_id=S1083318810002500&rfr_iscdi=true